Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Guldberg

Showing results (31-40 of 101) with videos related to

Pageof 11
Sort By:
Journal of Inherited Metabolic Disease|August 13, 1998
Aberrant phenylalanine metabolism in phenylketonuria heterozygotesP Guldberg, K F Henriksen, H C Lou, et al.
Human Mutation|January 1, 1996
DGGE analysis as supplement to SSCP analysis of the phenylalanine hydroxylase gene: detection of eight (one de novo, seven inherited) of nine remaining Norwegian PKU mutationsH G Eiken, P M Knappskog, P Guldberg, et al.
The Journal of Biological Chemistry|August 18, 2001
Methylation-dependent silencing of the reduced folate carrier gene in inherently methotrexate-resistant human breast cancer cellsJ Worm, A F Kirkin, K N Dzhandzhugazyan, et al.
European Journal of Human Genetics : EJHG|February 5, 1998
A molecular survey of phenylketonuria in Iceland: identification of a founding mutation and evidence of predominant Norse settlementP Guldberg, J Zschocke, A Dagbjartsson, et al.
Genomics|May 15, 1994
Molecular heterogeneity of nonphenylketonuria hyperphenylalaninemia in 25 Danish patientsP Guldberg, K F Henriksen, B Thöny, et al.
Acta Oncologica (Stockholm, Sweden)|September 15, 2000
TP53 mutation is an independent prognostic marker for poor outcome in both node-negative and node-positive breast cancerJ Overgaard, M Yilmaz, P Guldberg, et al.
Blood|May 30, 1998
Alterations of the MMAC1/PTEN gene in lymphoid malignanciesK Grønbaek, J Zeuthen, P Guldberg, et al.
The Journal of Investigative Dermatology|January 29, 2000
Mutation and allelic loss of the PTEN/MMAC1 gene in primary and metastatic melanoma biopsiesA Birck, V Ahrenkiel, J Zeuthen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 2000
Heterogeneity in the clinical phenotype of TP53 mutations in breast cancer patientsJ Alsner, M Yilmaz, P Guldberg, et al.
Molecular Genetics and Metabolism|June 5, 1999
Long-term beneficial effects of the phenylalanine-restricted diet in late-diagnosed individuals with phenylketonuriaR Koch, K Moseley, J Ning, et al.
Pageof 11

Showing results (31-40 of 101) with videos related to

Sort By:
Pageof 11
Journal of Inherited Metabolic Disease|August 13, 1998
Aberrant phenylalanine metabolism in phenylketonuria heterozygotesP Guldberg, K F Henriksen, H C Lou, et al.
Human Mutation|January 1, 1996
DGGE analysis as supplement to SSCP analysis of the phenylalanine hydroxylase gene: detection of eight (one de novo, seven inherited) of nine remaining Norwegian PKU mutationsH G Eiken, P M Knappskog, P Guldberg, et al.
The Journal of Biological Chemistry|August 18, 2001
Methylation-dependent silencing of the reduced folate carrier gene in inherently methotrexate-resistant human breast cancer cellsJ Worm, A F Kirkin, K N Dzhandzhugazyan, et al.
European Journal of Human Genetics : EJHG|February 5, 1998
A molecular survey of phenylketonuria in Iceland: identification of a founding mutation and evidence of predominant Norse settlementP Guldberg, J Zschocke, A Dagbjartsson, et al.
Genomics|May 15, 1994
Molecular heterogeneity of nonphenylketonuria hyperphenylalaninemia in 25 Danish patientsP Guldberg, K F Henriksen, B Thöny, et al.
Acta Oncologica (Stockholm, Sweden)|September 15, 2000
TP53 mutation is an independent prognostic marker for poor outcome in both node-negative and node-positive breast cancerJ Overgaard, M Yilmaz, P Guldberg, et al.
Blood|May 30, 1998
Alterations of the MMAC1/PTEN gene in lymphoid malignanciesK Grønbaek, J Zeuthen, P Guldberg, et al.
The Journal of Investigative Dermatology|January 29, 2000
Mutation and allelic loss of the PTEN/MMAC1 gene in primary and metastatic melanoma biopsiesA Birck, V Ahrenkiel, J Zeuthen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 2000
Heterogeneity in the clinical phenotype of TP53 mutations in breast cancer patientsJ Alsner, M Yilmaz, P Guldberg, et al.
Molecular Genetics and Metabolism|June 5, 1999
Long-term beneficial effects of the phenylalanine-restricted diet in late-diagnosed individuals with phenylketonuriaR Koch, K Moseley, J Ning, et al.
Pageof 11